Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified. While there is found to be an impact of sex steroids on sleep, and sex-dependent differences in the impact of sleep duration and quality on insulin resistance (IR), there is limited available information regarding the impact of Gender Affirming Hormone Therapy (GAHT) for transgender individuals on sleep and IR. Our study aims to quantify the impacts of GAHT on sleep and IR in the pediatric transgender population as well as determine the degree of correlation of sleep to IR in this population.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Sleep Duration as measured by actigraphy device.
Timeframe: baseline, 12 months
Change in Subjective Sleep Quality as measured by sleep questionnaires
Timeframe: baseline, 12 months
Change in Objective Sleep Quality as measured by actigraphy device
Timeframe: baseline, 12 months
Change in Insulin Resistance as measured by aggregation of lab results
Timeframe: baseline, 12 months